These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 11589830)

  • 1. Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine.
    Leifert JA; Lindencrona JA; Charo J; Whitton JL
    Hum Gene Ther; 2001 Oct; 12(15):1881-92. PubMed ID: 11589830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction.
    Rodriguez F; Zhang J; Whitton JL
    J Virol; 1997 Nov; 71(11):8497-503. PubMed ID: 9343207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.
    Rodriguez F; Harkins S; Redwine JM; de Pereda JM; Whitton JL
    J Virol; 2001 Nov; 75(21):10421-30. PubMed ID: 11581410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.
    Zhang M; Ishii K; Hisaeda H; Murata S; Chiba T; Tanaka K; Li Y; Obata C; Furue M; Himeno K
    Immunology; 2004 Aug; 112(4):567-74. PubMed ID: 15270727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.
    Palomba ML; Roberts WK; Dao T; Manukian G; Guevara-Patiño JA; Wolchok JD; Scheinberg DA; Houghton AN
    Clin Cancer Res; 2005 Jan; 11(1):370-9. PubMed ID: 15671568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA immunization of HLA transgenic mice with a plasmid expressing mycobacterial heat shock protein 65 results in HLA class I- and II-restricted T cell responses that can be augmented by cytokines.
    Charo J; Sundbäck M; Geluk A; Ottenhoff T; Kiessling R
    Hum Gene Ther; 2001 Sep; 12(14):1797-804. PubMed ID: 11560772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
    Wild J; Bojak A; Deml L; Wagner R
    Vaccine; 2004 Apr; 22(13-14):1732-43. PubMed ID: 15068857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes.
    Leifert JA; Holler PD; Harkins S; Kranz DM; Whitton JL
    Gene Ther; 2003 Dec; 10(25):2067-73. PubMed ID: 14595379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous immunisation with a Wilms' tumour 1 epitope and its ubiquitin fusions results in enhanced cell mediated immunity and tumour rejection in C57BL/6 mice.
    Eslami NS; Shokrgozar MA; Mousavi A; Azadmanesh K; Nomani A; Apostolopoulos V; Day S; Amanzadeh A; Alimohammadian MH
    Mol Immunol; 2012 Jul; 51(3-4):325-31. PubMed ID: 22525006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
    André P; Groettrup M; Klenerman P; de Giuli R; Booth BL; Cerundolo V; Bonneville M; Jotereau F; Zinkernagel RM; Lotteau V
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13120-4. PubMed ID: 9789051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes.
    Wu Y; Kipps TJ
    J Immunol; 1997 Dec; 159(12):6037-43. PubMed ID: 9550402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
    Fissolo N; Riedl P; Reimann J; Schirmbeck R
    Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.
    Tellam J; Sherritt M; Thomson S; Tellam R; Moss DJ; Burrows SR; Wiertz E; Khanna R
    J Biol Chem; 2001 Sep; 276(36):33353-60. PubMed ID: 11435434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.